Tomomi Furihata
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism 17
- Cholinesterase and Neurodegenerative Diseases 8
- Neurology top 5%
- Barrier Structure and Function Studies 18
- Biochemistry top 2%
- Amino Acid Enzymes and Metabolism 8
- Oncology top 5%
- Drug Transport and Resistance Mechanisms 32
- Hepatology top 5%
- Hepatitis C virus research 8
-
- HIV/AIDS drug development and treatment 7
-
- Epigenetics and DNA Methylation 7
- Co-authors
- Kan ChibaKaoru KobayashiMasakiyo HosokawaNaohiko AnzaiTetsuo SatohSusumu WakaiKeiji SanoTsuyoshi Fukushima
- Cited by
- PharmacologyNeurologyBiochemistry
- Partner nations
- JapanUnited StatesAustria
In The Last Decade
Tomomi Furihata
95 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 110
- Pharmacology 270
- Neurology 246
- Biochemistry 211
- Oncology 485
- Hepatology 127
Countries citing papers authored by Tomomi Furihata
This map shows the geographic impact of Tomomi Furihata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomomi Furihata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomomi Furihata more than expected).
Fields of papers citing papers by Tomomi Furihata
This network shows the impact of papers produced by Tomomi Furihata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomomi Furihata. The network helps show where Tomomi Furihata may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tomomi Furihata, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 2 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 18 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 7 | |
| 9 | 2021 | 12 | |
| 10 | 2020 | 20 | |
| 11 | 2020 | 16 | |
| 12 | 2020 | 39 | |
| 13 | 2016 | 5 | |
| 14 | 2015 | 15 | |
| 15 | 2015 | 6 | |
| 16 | 2012 | 56 | |
| 17 | 2007 | 21 | |
| 18 | 2006 | 32 | |
| 19 | 2005 | 37 | |
| 20 | 2004 | 22 |
About Tomomi Furihata
Tomomi Furihata is a scholar working on Neurology, Pharmacology and Biochemistry, having authored 98 papers that have together received 1.9k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (32 papers), Barrier Structure and Function Studies (18 papers), Pharmacogenetics and Drug Metabolism (17 papers), Amino Acid Enzymes and Metabolism (8 papers), Cholinesterase and Neurodegenerative Diseases (8 papers), Hepatitis C virus research (8 papers), HIV/AIDS drug development and treatment (7 papers) and Epigenetics and DNA Methylation (7 papers). The work is most often cited by research in Pharmacology (270 citations), Neurology (246 citations) and Biochemistry (211 citations). Tomomi Furihata has collaborated with scholars based in Japan, United States and Austria. Frequent co-authors include Kan Chiba, Kaoru Kobayashi, Masakiyo Hosokawa, Naohiko Anzai, Tetsuo Satoh, Susumu Wakai, Keiji Sano, Tsuyoshi Fukushima, Kosuke Saito and Hidetaka Akita. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.